BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 26884147)

  • 1. Blockade of CD73 delays glioblastoma growth by modulating the immune environment.
    Azambuja JH; Schuh RS; Michels LR; Iser IC; Beckenkamp LR; Roliano GG; Lenz GS; Scholl JN; Sévigny J; Wink MR; Stefani MA; Battastini AMO; Figueiró F; Teixeira HF; Braganhol E
    Cancer Immunol Immunother; 2020 Sep; 69(9):1801-1812. PubMed ID: 32350590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of caveolin-1 on the expression of tight junction-associated proteins in rat glioma-derived microvascular endothelial cells.
    Li Y; Liu LB; Ma T; Wang P; Xue YX
    Int J Clin Exp Pathol; 2015; 8(10):13067-74. PubMed ID: 26722502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of Novel Non-Nucleoside Inhibitors Interacting with Dizinc Ions of CD73.
    Shi C; Chang L; Wang J; Dai J; Xu W; Tang J; Mei W; Zhang C; Wang Z; Liao Y; Zhang X; Jiang W; Zhang G; Zhao Z; Xu Y; Zhu L; Li H
    J Med Chem; 2024 Jun; 67(11):9686-9708. PubMed ID: 38809692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood-brain barrier breakdown in septic encephalopathy and brain tumours.
    Davies DC
    J Anat; 2002 Jun; 200(6):639-46. PubMed ID: 12162731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correction to: CD73 expression in normal and pathological human hepatobiliopancreatic tissues.
    Sciarra A; Monteiro I; Ménétrier-Caux C; Caux C; Gilbert B; Halkic N; La Rosa S; Romero P; Sempoux C; de Leval L
    Cancer Immunol Immunother; 2019 Mar; 68(3):529. PubMed ID: 30721340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracellular Adenosine Production by ecto-5'-Nucleotidase (CD73) Enhances Radiation-Induced Lung Fibrosis.
    Wirsdörfer F; de Leve S; Cappuccini F; Eldh T; Meyer AV; Gau E; Thompson LF; Chen NY; Karmouty-Quintana H; Fischer U; Kasper M; Klein D; Ritchey JW; Blackburn MR; Westendorf AM; Stuschke M; Jendrossek V
    Cancer Res; 2016 May; 76(10):3045-56. PubMed ID: 26921334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD73: A Promising Biomarker in Cancer Patients.
    Turiello R; Pinto A; Morello S
    Front Pharmacol; 2020; 11():609931. PubMed ID: 33364969
    [No Abstract]   [Full Text] [Related]  

  • 8. Improved efficacy against malignant brain tumors with EGFRwt/EGFRvIII targeting immunotoxin and checkpoint inhibitor combinations.
    Chandramohan V; Bao X; Yu X; Parker S; McDowall C; Yu YR; Healy P; Desjardins A; Gunn MD; Gromeier M; Nair SK; Pastan IH; Bigner DD
    J Immunother Cancer; 2019 May; 7(1):142. PubMed ID: 31142380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploration of Involved Key Genes and Signaling Diversity in Brain Tumors.
    Nasser MM; Mehdipour P
    Cell Mol Neurobiol; 2018 Mar; 38(2):393-419. PubMed ID: 28493234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in clinical neurology through the journal "Neurological Sciences" (2015-2016).
    Di Donato I; Federico A
    Neurol Sci; 2017 Jan; 38(1):9-18. PubMed ID: 28093657
    [No Abstract]   [Full Text] [Related]  

  • 11. Ecto-5'-nucleotidase, CD73, is an endothelium-derived hyperpolarizing factor synthase.
    Ohta M; Toyama K; Gutterman DD; Campbell WB; Lemaître V; Teraoka R; Miura H
    Arterioscler Thromb Vasc Biol; 2013 Mar; 33(3):629-36. PubMed ID: 23288168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of CD73 in Disease: Promising Prognostic Indicator and Therapeutic Target.
    Yang J; Liao X; Yu J; Zhou P
    Curr Med Chem; 2018; 25(19):2260-2271. PubMed ID: 29345574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting CD73 and downstream adenosine receptor signaling in triple-negative breast cancer.
    Allard B; Turcotte M; Stagg J
    Expert Opin Ther Targets; 2014 Aug; 18(8):863-81. PubMed ID: 24798880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of extracellular-5'-nucleotidase/CD73 in glioma peritumoural brain edema.
    Wang B; Wang D; Zhu Z; Wang W; Zhang X; Tang F; Zhou Y; Wang H; Liu M; Yao X; Yan X
    Neurol Sci; 2016 Apr; 37(4):603-11. PubMed ID: 26884147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelial cell barrier impairment induced by glioblastomas and transforming growth factor beta2 involves matrix metalloproteinases and tight junction proteins.
    Ishihara H; Kubota H; Lindberg RL; Leppert D; Gloor SM; Errede M; Virgintino D; Fontana A; Yonekawa Y; Frei K
    J Neuropathol Exp Neurol; 2008 May; 67(5):435-48. PubMed ID: 18431253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IFN-beta regulates CD73 and adenosine expression at the blood-brain barrier.
    Niemelä J; Ifergan I; Yegutkin GG; Jalkanen S; Prat A; Airas L
    Eur J Immunol; 2008 Oct; 38(10):2718-26. PubMed ID: 18825744
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.